Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Andrea Lynne Brennan"'
Autor:
Tara C Mitchell, Robert H Vonderheide, Carl H June, Gabriela Plesa, Simon F Lacey, Irina Kulikovskaya, Vanessa E Gonzalez, Andrea Lynne Brennan, Gerald P Linette, E. John Wherry, Amy Marshall, Karen Dengel, Lester Lledo, Joan Gilmore, Joanne Shea, Amanda Cervini, Tina Matlawski, Julia Tchou, Paul Zhang, Lynn M. Schuchter, Ravi K Amaravadi, Robert Orlowski, Xiaowei Xu, Alexander C. Huang, Payal D Shah
Supplementary Figure 1. : Representative immunohistochemical staining for Subject 74 with metastatic melanoma; lymph node biopsy. Panel A: pS6 staining prior to infusion; Panel B: pS6 staining at post-infusion biopsy; Panel C: Ki-67 staining prior to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::231510cf468ded7c965e54cfc035befb
https://doi.org/10.1158/2767-9764.22535386.v1
https://doi.org/10.1158/2767-9764.22535386.v1
Autor:
Tara C Mitchell, Robert H Vonderheide, Carl H June, Gabriela Plesa, Simon F Lacey, Irina Kulikovskaya, Vanessa E Gonzalez, Andrea Lynne Brennan, Gerald P Linette, E. John Wherry, Amy Marshall, Karen Dengel, Lester Lledo, Joan Gilmore, Joanne Shea, Amanda Cervini, Tina Matlawski, Julia Tchou, Paul Zhang, Lynn M. Schuchter, Ravi K Amaravadi, Robert Orlowski, Xiaowei Xu, Alexander C. Huang, Payal D Shah
Supplementary Figure 2: Representative immunohistochemical staining for Subject 27 with metastatic triple-negative breast cancer; lymph node biopsy. Panel A shows CD8 staining prior to infusion and Panel B shows CD8 staining at the time of post-infus
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::129c00eb78c481393aacb977d0f1d338
https://doi.org/10.1158/2767-9764.22535383
https://doi.org/10.1158/2767-9764.22535383
Autor:
Tara C Mitchell, Robert H Vonderheide, Carl H June, Gabriela Plesa, Simon F Lacey, Irina Kulikovskaya, Vanessa E Gonzalez, Andrea Lynne Brennan, Gerald P Linette, E. John Wherry, Amy Marshall, Karen Dengel, Lester Lledo, Joan Gilmore, Joanne Shea, Amanda Cervini, Tina Matlawski, Julia Tchou, Paul Zhang, Lynn M. Schuchter, Ravi K Amaravadi, Robert Orlowski, Xiaowei Xu, Alexander C. Huang, Payal D Shah
Purpose: Treatments are limited for metastatic melanoma (MM) and triple-negative breast cancer (mTNBC). This pilot phase I trial (NCT03060356) examined the safety and feasibility of intravenous RNA- electroporated chimeric antigen receptor (CAR) T ce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eb461f29152df1117010a2204b876486
https://doi.org/10.1158/2767-9764.c.6547846.v1
https://doi.org/10.1158/2767-9764.c.6547846.v1